Last checked at 2 Sep 2022 17:26
2 September 2022
Kromek Group plc
("Kromek" or the "Group")
Notice of AGM and Publication of Annual Report
Kromek Group plc, a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, gives notice that its Annual General Meeting ("AGM") will be held at 9.30am on 28 September 2022 at The Coxon Building, North East Technology Park (NETPark), John Walker Road, Sedgefield, County Durham, TS21 3FE.
The notice of AGM and form of proxy, along with the Group's annual report and accounts for the year ended 30 April 2022, have today been posted to those shareholders who have requested paper communications. These documents are also available on the Investor Relations section of the Group's website at https://www.kromek.com/investor-relations/ and can be accessed by clicking on the "AGM 2022" page.
For further information, please contact:
Kromek Group plc | |
Arnab Basu, CEO Paul Farquhar, CFO | +44 (0)1740 626 060 |
finnCap Ltd (Nominated Adviser and Broker) | |
Geoff Nash/Seamus Fricker/George Dollemore - Corporate Finance | +44 (0)20 7220 0500 |
Tim Redfern/Charlotte Sutcliffe - ECM | |
Gracechurch Group (Financial PR) | |
Harry Chathli/Claire Norbury | +44 (0)20 3488 7510 |
About Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.
The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of 'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.
Further information is available at www.kromek.com.